Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Clinical Genitourinary Cancer
|
December 5, 2025
Ipilimumab and Nivolumab in Renal Cell Carcinoma: Real-World Experience in Rare Variant Renal Cell Carcinoma, Brain Metastases and Impact of Immune-Related Adverse Events and Steroid Use
Tobias Peres, James Larkin
Aktuelle Urologie
|
March 27, 2024
Tobias Peres, Aurelius Omlin
Aktuelle Urologie
|
June 6, 2024
Tobias Peres, Aurelius Omlin
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 30, 2025
Neurological immune-related adverse events with immune checkpoint inhibitors: collaboration is key
Anadil Javaid, Tobias Peres, James Larkin
Frontiers in Oncology
|
April 28, 2025
Case Report: Abiraterone in brain metastases from prostate cancer
Tobias Peres, Stefanie Aeppli, Stefanie Fischer, et al.
Current Oncology (Toronto, Ont.)
|
February 25, 2025
First Single-Centre Experience with the Novel HIF-α Inhibitor Belzutifan in Switzerland
Tobias Peres, Stefanie Aeppli, Stefanie Fischer, et al.
Expert Review of Anticancer Therapy
|
January 9, 2025
Current and emerging treatment options for BRAFV600-mutant melanoma
Anadil Javaid, Tobias Peres, Javier Pozas, et al.
Journal of Cancer Research and Clinical Oncology
|
February 8, 2024
Metronomic cyclophosphamide for bone marrow carcinomatosis in metastatic castration-resistant prostate cancer
Tobias Peres, Stefanie Aeppli, Stefanie Fischer, et al.
Cancer Medicine
|
October 22, 2024
Factors Guiding Clinical Decision-Making in Genitourinary Oncology
Marie Wosny, Stefanie Aeppli, Stefanie Fischer, et al.
Targeted Oncology
|
June 10, 2025
A Bayesian Network Meta-analysis of Systemic Treatments for Metastatic Castration-Resistant Prostate Cancer in First- and Subsequent Lines
Marie Wosny, Stefanie Aeppli, Stefanie Fischer, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Clinical Genitourinary Cancer
|
December 5, 2025
Ipilimumab and Nivolumab in Renal Cell Carcinoma: Real-World Experience in Rare Variant Renal Cell Carcinoma, Brain Metastases and Impact of Immune-Related Adverse Events and Steroid Use
Tobias Peres, James Larkin
Aktuelle Urologie
|
March 27, 2024
Tobias Peres, Aurelius Omlin
Aktuelle Urologie
|
June 6, 2024
Tobias Peres, Aurelius Omlin
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 30, 2025
Neurological immune-related adverse events with immune checkpoint inhibitors: collaboration is key
Anadil Javaid, Tobias Peres, James Larkin
Frontiers in Oncology
|
April 28, 2025
Case Report: Abiraterone in brain metastases from prostate cancer
Tobias Peres, Stefanie Aeppli, Stefanie Fischer, et al.
Current Oncology (Toronto, Ont.)
|
February 25, 2025
First Single-Centre Experience with the Novel HIF-α Inhibitor Belzutifan in Switzerland
Tobias Peres, Stefanie Aeppli, Stefanie Fischer, et al.
Expert Review of Anticancer Therapy
|
January 9, 2025
Current and emerging treatment options for BRAFV600-mutant melanoma
Anadil Javaid, Tobias Peres, Javier Pozas, et al.
Journal of Cancer Research and Clinical Oncology
|
February 8, 2024
Metronomic cyclophosphamide for bone marrow carcinomatosis in metastatic castration-resistant prostate cancer
Tobias Peres, Stefanie Aeppli, Stefanie Fischer, et al.
Cancer Medicine
|
October 22, 2024
Factors Guiding Clinical Decision-Making in Genitourinary Oncology
Marie Wosny, Stefanie Aeppli, Stefanie Fischer, et al.
Targeted Oncology
|
June 10, 2025
A Bayesian Network Meta-analysis of Systemic Treatments for Metastatic Castration-Resistant Prostate Cancer in First- and Subsequent Lines
Marie Wosny, Stefanie Aeppli, Stefanie Fischer, et al.
Page
of 2